⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7496575 | 1.00 | — | — | |
| SCHEMBL1726593 | 1.00 | — | — | |
| SCHEMBL7496569 | 1.00 | — | — | |
| SCHEMBL64396 | 1.00 | — | — | |
| SCHEMBL1723503 | 1.00 | — | — | |
| SCHEMBL1724943 | 1.00 | — | — | |
| SCHEMBL606385 | 1.00 | — | — | |
| SCHEMBL29208889 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3332500 | 0.98 | CCR5 (0.36) | — | |
| SCHEMBL8704625 | 0.93 | EPAS1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735539-A | 4-Oxo-pyrrolidine derivative and preparation method and application thereof | 上海应用技术大学 | 2025-04-01 | — | — | CN | claimed |
| CN-116396290-B | Method for preparing moxifloxacin intermediate (S, S) -2, 8-diazabicyclo [4,3,0] nonane | 南京杰运医药科技有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-113789310-B | Transaminase and application thereof in preparation of moxifloxacin or intermediate thereof | 上海予君生物科技发展有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116396290-A | Method for preparing moxifloxacin intermediate (S, S) -2, 8-diazabicyclo [4,3,0] nonane | 南京杰运医药科技有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-110105273-B | Preparation method of important intermediate of moxifloxacin | 江苏省药物研究所有限公司 | 2023-06-13 | — | — | CN | claimed |
| WO-2022166436-A1 | METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE (S, S)-2, 8-DIAZABICYCLO [4, 3, 0] NONANE | 台州市生物医化产业研究院有限公司 | 2022-08-11 | — | — | WO | claimed |
| WO-2022166440-A1 | METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE, (S,S)-2,8-DIAZABICYCLO[4,3,0]NONANE | 台州市生物医化产业研究院有限公司 | 2022-08-11 | — | — | WO | claimed |
| CN-112939847-B | Method for preparing moxifloxacin intermediate (S, S) -2, 8-diazabicyclo [4,3,0] nonane | 台州市生物医化产业研究院有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-110794046-B | Method for detecting 2,4, 5-trifluoro-3-methoxybenzoyl chloride in moxifloxacin intermediate | 珠海润都制药股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-112920184-B | Method for preparing moxifloxacin intermediate (S, S) -2, 8-diazabicyclo [4,3,0] nonane | 台州市生物医化产业研究院有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-20110137036-A1 | SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A (IT) | 2011-06-09 | — | — | US | claimed |
| US-7692015-B2 | Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer | LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) | 2010-04-06 | — | — | US | claimed |
| WO-2026085629-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Université de Montréal (CA) | 2026-04-30 | — | — | WO | disclosed |
| CN-119735539-A | 4-Oxo-pyrrolidine derivative and preparation method and application thereof | 上海应用技术大学 | 2025-04-01 | — | — | CN | disclosed |
| CN-119735539-A | 4-Oxo-pyrrolidine derivative and preparation method and application thereof | 上海应用技术大学 | 2025-04-01 | — | — | CN | disclosed |
| US-20250034120-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | RIBON THERAPEUTICS, INC. | 2025-01-30 | — | — | US | disclosed |
| EP-0592868-A1 | Quinolonecarboxylic acids | BAYER AG (DE) | 1994-04-20 | — | — | EP | disclosed |
| EP-0591808-A1 | Quinolonecarboxylic acids | BAYER AG (DE) | 1994-04-13 | — | — | EP | disclosed |
| EP-0550903-A1 | Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents | BAYER AG (DE) | 1993-07-14 | — | — | EP | disclosed |
| EP-0523512-A1 | 8-vinyl- and 8-ethinyl-quinolone carboxylic acids | BAYER AG (DE) | 1993-01-20 | — | — | EP | disclosed |